glucagon agonist retatrutide 🎙️ NEW EPISODE: Retatrutide—The Triple *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide (LY3437943): Mechanism of Action

246 Adjusting for age, sex, race/ethnicity, income, education, and food security status, individuals experiencing nutrition insecurity were 40-60% more likely to have obesity as well as type 2 diabetes, heart disease, hypertension, and hypercholesterolemia

GLP-1 and GIP receptor agonistsare unlikely to cause severe hypoglycemia unless combined with other medications for diabetes

Does weight gain affect libido

Sci Signal 8:re8 Sugao Y, Yao T, Kubo C, Tsuneyoshi M (1997) Improved prognosis of solid-type poorly differentiated colorectal adenocarcinoma: a clinicopathological and immunohistochemical study

CD36 and ACAT-1 are connected with macrophage foam cell formation and aortic smooth muscle cell proliferation